Theriva Biologics, Inc. Profile Avatar - Palmy Investing

Theriva Biologics, Inc.

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …

Biotechnology
US, Rockville [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of TOVX's Analysis
CIK: 894158 CUSIP: - ISIN: US87164U4094 LEI: - UEI: -
Secondary Listings
TOVX has no secondary listings inside our databases.